| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.76B | 9.28B | 9.74B | 10.43B | 8.05B | 8.89B |
| Gross Profit | 9.76B | 8.95B | 9.72B | 10.40B | 8.01B | 8.83B |
| EBITDA | 403.00M | 1.79B | 1.26B | 2.01B | 809.00M | 1.53B |
| Net Income | 1.03B | 954.00M | 632.00M | 972.00M | 333.00M | 559.00M |
Balance Sheet | ||||||
| Total Assets | 561.17B | 548.42B | 552.20B | 551.29B | 569.87B | 552.49B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 30.67B | 33.31B | 30.16B | 36.79B | 40.12B |
| Total Debt | 14.77B | 11.56B | 18.27B | 18.73B | 35.23B | 25.38B |
| Total Liabilities | 531.16B | 519.07B | 520.89B | 521.04B | 537.55B | 518.90B |
| Stockholders Equity | 29.11B | 28.45B | 30.43B | 29.40B | 31.48B | 32.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.35B | -2.16B | -19.88B | 11.13B | 11.56B |
| Operating Cash Flow | 0.00 | 1.65B | 2.64B | -19.22B | 11.28B | 11.69B |
| Investing Cash Flow | 0.00 | 1.87B | 972.00M | 13.79B | -13.30B | -19.21B |
| Financing Cash Flow | 0.00 | 2.92B | -272.00M | -272.00M | -341.00M | -273.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥9.71B | 9.10 | ― | 2.98% | 5.57% | -23.26% | |
72 Outperform | ¥12.66B | 7.90 | ― | 3.73% | 13.77% | 19.08% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ¥10.88B | 6.20 | ― | 1.28% | 5.92% | ― | |
63 Neutral | ¥9.86B | 6.96 | ― | 4.09% | 5.91% | 5.03% | |
60 Neutral | ¥8.90B | 89.45 | ― | 2.92% | 7.74% | -92.49% | |
48 Neutral | ¥8.16B | ― | ― | 2.11% | 8.11% | 68.98% |